Item 9A. Controls and Procedures
Item 9A. Controls and Procedures.
Inherent Limitations on Effectiveness of Controls
In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Annual Report on Form 10-K. Based on the evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective at the reasonable assurance level as of December 31, 2024.
Management's Annual Report on Internal Control Over Financial Reporting
Management, under the supervision of our Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over our financial reporting as required by the Sarbanes-Oxley Act of 2002 and as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.
Our management evaluated the design and operating effectiveness of our internal control over financial reporting based on the criteria established in the Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management concluded that the Company’s internal control over financial reporting was effective as of December 31, 2024. Our independent registered public accounting firm, Deloitte & Touche LLP, has issued an attestation report on the Company’s internal control over financial reporting as of December 31, 2024, which is included below.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended December 31, 2024 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
114
TABLE OF CONTENTS
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the shareholders and the Board of Directors of Opendoor Technologies Inc.
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of Opendoor Technologies Inc. and subsidiaries (the “Company”) as of December 31, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2024, of the Company and our report dated February 27, 2025, expressed an unqualified opinion on those financial statements.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ Deloitte & Touche LLP
San Francisco, California
February 27, 2025
115
TABLE OF CONTENTS
OPENDOOR TECHNOLOGIES INC.
Item 9B. Other Information.
During the three months ended December 31, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Director Departures
On February 26, 2025, Cipora Herman provided a written notice to the Company of her intent to resign from the Board, and all committees thereof, as applicable, effective as of February 28, 2025. Also on February 26, 2025, John Rice provided a written notice to the Company of his intent to retire from the Board at the end of his current term. Mr. Rice will not stand for re-election at the 2025 annual meeting of stockholders (the “Annual Meeting”), and will continue to serve as a member of the Board, Lead Independent Director, and a member of the Nominating and Corporate Governance Committee of the Board until the Annual Meeting.
Ms. Herman’s resignation and Mr. Rice’s decision not to stand for re-election were not due to any disagreement with the Company, its management, or other members of the Board. The Board has also reduced its size from nine to eight directors, effective February 28, 2025, and further reduced its size from eight to seven directors, effective at the conclusion of the Annual Meeting.
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
Not applicable.
116
TABLE OF CONTENTS
OPENDOOR TECHNOLOGIES INC.
PART III
Item 10. Directors, Executive Officers and Corporate Governance.
The following information with respect to our board of directors and executive officers is presented as of February 27, 2025:
Name
Age
Position at Opendoor Technologies Inc.
Principal Employment
Carrie Wheeler
53 Chief Executive Officer & Director
Same
Selim Freiha
53 Chief Financial Officer
Same
Sydney Schaub
44 Chief Legal Officer
Same
Adam Bain
51 Director
Co-Managing Partner, 01 Advisors
David Benson
65 Director
Former President of Fannie Mae
Eric Feder
54 Director
President of LEN X , LLC
Dana Hamilton
56 Director
Co-founder and President of Ameriton LLC
Cipora Herman
51 Director
Former Chief Financial Officer of LA28
Pueo Keffer
43 Director
Managing Director, Access Technology Ventures
John Rice 58 Lead Independent Director
Chief Executive Officer of Management Leadership for Tomorrow
Glenn Solomon
56 Director
Managing Partner, Notable Capital
Other information required by this item will be included in our definitive proxy statement for our 2025 annual meeting of stockholders to be filed by us with the SEC within 120 days after the end of our fiscal year ended December 31, 2024 (the “Proxy Statement”) and is incorporated herein by reference.
Code of Business Conduct and Ethics
We have a written Code of Business Conduct and Ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of our Code of Business Conduct and Ethics is posted on our investor relations website, investor.opendoor.com . We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding amendment to, or waiver from, a provision of our Code of Business Conduct and Ethics, as well as Nasdaq’s requirement to disclose waivers with respect to directors and executive officers, by posting such information on our website at the address and location specified above. The information on any of our websites is deemed not to be incorporated in this Annual Report on Form 10-K or to be part of this Annual Report on Form 10-K.
Insider Trading Policies and Procedures
Our Board has adopted an Insider Trading and Trading Windows Policy (“Insider Trading Policy”) that governs the purchase, sale, and/or other disposition of the Company’s securities and is applicable to all directors, officers and other employees of the Company, as well as the Company itself. We believe our Insider Trading Policy is reasonably designed to promote compliance with insider trading laws, rules and regulations, as well as listing standards applicable to us. A copy of our Insider Trading Policy is filed with this Annual Report on Form 10-K as Exhibit 19.1.
Item 11. Executive Compensation.
The information required by this item will be included in the Proxy Statement and is incorporated herein by reference.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
The information required by this item will be included in the Proxy Statement and is incorporated herein by reference.
117
TABLE OF CONTENTS
OPENDOOR TECHNOLOGIES INC.
Item 13. Certain Relationships and Related Transactions, and Director Independence.
The information required by this item will be included in the Proxy Statement and is incorporated herein by reference.
Item 14. Principal Accountant Fees and Services.
The information required by this item about our principal accountant, Deloitte & Touche LLP (PCAOB ID No. 34 ), will be included in the Proxy Statement and is incorporated herein by reference.
118
TABLE OF CONTENTS
OPENDOOR TECHNOLOGIES INC.
PART IV
Item 15. Exhibit and Financial Statement Schedules.
(a) Documents files as part of this Annual Report on Form 10-K:
1. Financial Statements
Refer to Index to Consolidated Financial Statements in “Part II – Item 8. Financial Statements and Supplementary Data” herein.
2. Financial Statement Schedules
Pursuant to the requirements of Rule 5-04(c) of Regulation S-X, the following schedule is filed as part of this Annual Report on Form 10-K and should be read in conjunction with the financial statements contained in “Part II – Item 8. Financial Statements and Supplementary Data” herein.
Schedule I – Condensed Financial Information of Opendoor Technologies Inc. (Parent Company)
All other financial statement schedules for the Company have been included in the consolidated financial statements or the related footnotes, or are either inapplicable or not required.
3. Exhibits †
The following is a list of exhibits filed as part of this Annual Report on Form 10-K.
Exhibit
No. Description Form File No. Exhibit Filing Date Filed Herewith
2.1 Agreement and Plan of Merger, dated as of September 15, 2020, by and among Social Capital Hedosophia Corp. II, Hestia Merger Sub Inc. and Opendoor Labs Inc.
8-K 001-39253
2.1 09/17/2020
3.1 Certificate of Incorporation of Opendoor Technologies Inc.
8-K 001-39253 3.1 12/18/2020
3.2 Amended and Restated Bylaws of Opendoor Technologies Inc.
8-K 001-39253 3.1 01/24/2023
4.1 Specimen Common Stock Certificate of Opendoor Technologies Inc.
S-4/A 333-249302 4.5 11/06/2020
4.2 Warrant Agreement, dated April 27, 2020, between Social Capital Hedosophia Holdings Corp. II. and Continental Stock Transfer & Trust Company, as warrant agent
8-K 001-39253 4.1 04/30/2020
4.3 Amendment to Warrant Agreement, dated March 22, 2021, between Opendoor Technologies Inc. and American Stock Transfer & Trust Company, LLC, as warrant agent
10-Q 001-39253
4.3 05/12/2021
4.4 Warrant to Purchase Shares of Common Stock of Opendoor Technologies Inc., dated July 28, 2022, to Zillow, Inc.
8-K 001-39253 99.2 08/05/2022
4.5 Indenture, dated as of August 20, 2021, between Opendoor Technologies Inc. and U.S. Bank National Association, as trustee
8-K 001-39253
4.1 08/24/2021
4.6 Description of Securities
*
10.1 Sponsor Support Agreement, dated September 15, 2020, by and among SCH Sponsor II LLC, the Company, each officer and director of the Registrant and Opendoor Labs Inc.
8-K/A 001-39253 10.2 09/17/2020
10.2 Opendoor Holders Support Agreement, dated September 15, 2020, by and among the Company , Opendoor Labs Inc. and certain stockholders of Opendoor Labs Inc.
8-K/A 001-39253 10.3 09/17/2020
119
TABLE OF CONTENTS
OPENDOOR TECHNOLOGIES INC.
Exhibit
No. Description Form File No. Exhibit Filing Date Filed Herewith
10.3 Form of Subscription Agreement, by and between Opendoor Labs Inc. and the undersigned subscriber party thereto
8-K/A 001-39253 10.1 09/17/2020
10.4 Amended and Restated Registration Rights Agreement, dated December 18, 2020, by and among the Company, SCH Sponsor II LLC, certain former stockholders of Opendoor Labs Inc., Cipora Herman, David Spillane and ChaChaCha SPAC B, LLC, Hedosophia Group Limited and 010118 Management, L.P.
8-K 001-39253 10.14 12/18/2020
10.5 Convertible Notes Exchange Agreement, dated as of September 14, 2020, by and among Opendoor Labs Inc. and the holders party thereto
S-4 333-249302 10.5 10/05/2020
10.6 # Form of Indemnification Agreement
8-K 001-39253 10.1 12/18/2020
10.7 # Opendoor Labs Inc. 2014 Stock Plan
S-4 333-249302 10.18 10/05/2020
10.8 # Form of Notice of Restricted Stock Unit Grant and RSU Terms and Conditions Under 2014 Stock Plan
S-4 333-249302 10.19 10/05/2020
10.9 # Form of Notice of Stock Option Grant and Stock Option Agreement under 2014 Stock Plan
S-4/A 333-249302 10.20 11/25/2020
10.10 # Opendoor Technologies Inc. 2020 Incentive Award Plan
8-K 001-39253 10.3 12/18/2020
10.11 # Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under 2020 Incentive Award Plan
8-K 001-39253 99.1 04/02/2021
10.12 # Form of Option Agreement under the 2020 Incentive Award Plan
10-Q 001-39253 10.1 11/10/2021
10.13 # Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (Canada) under 2020 Incentive Award Plan
10-Q 001-39253 10.1 08/11/2021
10.14 # Opendoor Technologies Inc. 2020 Employee Stock Purchase Plan
8-K 001-39253 10.4 12/18/2020
10.15 # Opendoor Technologies Inc. Amended and Restated 2020 Employee Stock Purchase Plan (effective as of February 8, 2023)
10-K
001-39253 10.15
02/23/2023
10.16
#
Form of Performance Restricted Stock Unit Grant Notice and Performance Restricted Stock Unit Agreement under 2020 Incentive Award Plan
10-Q
001-39253 10.2
05/02/2024
10.17
# Offer Letter Agreement, dated as of September 3, 2020, by and between Opendoor Labs Inc. and Carrie Wheeler
S-4/A 333-249302 10.32 11/27/2020
10.18
# Amendment of Letter Agreement, dated as of December 1, 2022, by and between Opendoor Technologies Inc. and Carrie Wheeler
10-K
001-39253 10.22
02/23/2023
10.19 # Opendoor Technologies Inc. Non-Employee Director Compensation Policy
10-Q
001-39253 10.1
11/02/2023
10.20
# Opendoor Technologies Inc. Executive Severance Plan
10-Q
001-39253 10.1
05/02/2024
10.21
# Change in Control Letter Agreement, dated as of January 31, 2022, by and between Opendoor Technologies Inc. and Carrie Wheeler
10-Q 001-39253 10.3 05/05/2022
10.22
Sales Agreement, dated May 2, 2024, by and among Opendoor Technologies Inc., Barclays Capital Inc. and Virtu Americas LLC
S-3ASR 333-279080 1.2
05/02/2024
10.23
# Opendoor Technologies Inc. 2022 Inducement Award Plan
S-8 333-266877 99.1 08/15/2022
120
TABLE OF CONTENTS
OPENDOOR TECHNOLOGIES INC.
Exhibit
No. Description Form File No. Exhibit Filing Date Filed Herewith
10.24
# Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement Under 2022 Inducement Award Plan
S-8 333-266877 99.2 08/15/2022
10.25
# Form of Stock Option Grant Notice and Stock Option Agreement Under 2022 Inducement Award Plan
S-8 333-266877 99.3 08/15/2022
10.26
#
Offer Letter Agreement, dated as of September 30, 2024, by and between Opendoor Labs Inc. and Selim Freiha
10-Q
001-39253 10.1
11/07/2024
10.27
#
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (India) under 2020 Incentive Award Plan
10-K
001-39253 10.32
02/23/2023
10.28
#
Offer Letter Agreement dated as of July 6, 2016, by and between Opendoor Labs Inc. and Christina Schwartz
10-Q
001-39253 10.1
05/04/2023
10.29
#
Offer Letter Agreement dated as of July 10, 2022, by and between Opendoor Labs Inc. and Sydney Schaub
10-Q
001-39253 10.2
05/04/2023
10.30
#
Offer Letter Agreement dated as of March 10, 2015, by and between Opendoor Labs Inc. and Megan Meyer
10-Q
001-39253 10.1
08/03/2023
10.31
#
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (India) Under 2022 Inducement Award Plan
10-K
001-39253 10.31
02/15/2024
10.32
#
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (Canada) Under 2022 Inducement Award Plan
10-K
001-39253 10.32
02/15/2024
10.33
#
T ransition Agreement, dated as of September 30, 2024, by and between Opendoor Technologies Inc ., Opendoor Labs Inc. and Christina Schwartz
10-Q
001-39253 10.2
11/07/2024
10.34
#
F orm of Director Offer Letter
*
19.1
I nsider Trading and Trading Window Policy
*
21.1 List of subsidiaries of Opendoor Technologies Inc.
*
23.1 Consent of Deloitte & Touche LLP
*
31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*
31.2 Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*
32.1 Certification of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
**
97.1
Policy for Recovery of Erroneously Awarded Compensation
10-K
001-39253 97.1
02/15/2024
101.INS Inline XBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document. *
101.SCH Inline XBRL Taxonomy Extension Schema Document. *
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document. *
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document. *
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document. *
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document. *
104 Cover Page Interactive Data File (as formatted as Inline XBRL and contained in Exhibit 101) *
121
TABLE OF CONTENTS
OPENDOOR TECHNOLOGIES INC.
________________
* Filed herewith.
** Furnished herewith.
# Indicates management contract or compensatory plan.
† Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.
Item 16. Form 10-K Summary.
None.
122
OPENDOOR TECHNOLOGIES INC.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
OPENDOOR TECHNOLOGIES INC.
Date: February 27, 2025 By: /s/ Carrie Wheeler
Name: Carrie Wheeler
Title: Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Signature Title Date
/s/ Carrie Wheeler
Chief Executive Officer and Director
(Principal Executive Officer)
February 27, 2025
Carrie Wheeler
/s/ Selim Freiha
Chief Financial Officer
(Principal Financial and Accounting Officer)
February 27, 2025
Selim Freiha
/s/ Adam Bain
Director February 27, 2025
Adam Bain
/s/ David Benson
Director February 27, 2025
David Benson
/s/ Eric Feder
Director February 27, 2025
Eric Feder
/s/ Dana Hamilton
Director February 27, 2025
Dana Hamilton
/s/ Cipora Herman
Director February 27, 2025
Cipora Herman
/s/ Pueo Keffer
Director February 27, 2025
Pueo Keffer
/s/ John Rice
Director February 27, 2025
John Rice
/s/ Glenn Solomon
Director February 27, 2025
Glenn Solomon
123